The most commonly observed FGFR3 mutations in bladder cancer include S249C, Y373C, R248C, and G370C mutations.18 These mutations can occur either on the extracellular or transmembrane domains of the receptor, and ultimately lead to ligand-independent dimerization and activation. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.